Business Description
ResMed Inc
NAICS : 339112
SIC : 3841
ISIN : US7611521078
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.2 | |||||
Equity-to-Asset | 0.68 | |||||
Debt-to-Equity | 0.25 | |||||
Debt-to-EBITDA | 0.78 | |||||
Interest Coverage | 23.55 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 11.29 | |||||
Beneish M-Score | -2.41 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.2 | |||||
3-Year EBITDA Growth Rate | 10.4 | |||||
3-Year EPS without NRI Growth Rate | 14.7 | |||||
3-Year FCF Growth Rate | -7.4 | |||||
3-Year Book Growth Rate | 17.7 | |||||
Future 3-5Y EPS without NRI Growth Rate | 13 | |||||
Future 3-5Y Total Revenue Growth Rate | 7.1 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 78.96 | |||||
9-Day RSI | 73.52 | |||||
14-Day RSI | 69.21 | |||||
6-1 Month Momentum % | 37.87 | |||||
12-1 Month Momentum % | -8.85 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.04 | |||||
Quick Ratio | 1.97 | |||||
Cash Ratio | 0.31 | |||||
Days Inventory | 170.35 | |||||
Days Sales Outstanding | 57.21 | |||||
Days Payable | 31.32 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.86 | |||||
Dividend Payout Ratio | 0.26 | |||||
3-Year Dividend Growth Rate | 4.1 | |||||
Forward Dividend Yield % | 0.89 | |||||
5-Year Yield-on-Cost % | 1.07 | |||||
3-Year Average Share Buyback Ratio | -0.5 | |||||
Shareholder Yield % | 0.94 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 55.78 | |||||
Operating Margin % | 28.12 | |||||
Net Margin % | 20.91 | |||||
FCF Margin % | 23.36 | |||||
ROE % | 22.37 | |||||
ROA % | 14.12 | |||||
ROIC % | 17.46 | |||||
ROC (Joel Greenblatt) % | 62.37 | |||||
ROCE % | 21.42 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 33.06 | |||||
Forward PE Ratio | 26.32 | |||||
PE Ratio without NRI | 29.69 | |||||
Shiller PE Ratio | 51.61 | |||||
Price-to-Owner-Earnings | 32.1 | |||||
PEG Ratio | 1.95 | |||||
PS Ratio | 6.93 | |||||
PB Ratio | 6.83 | |||||
Price-to-Tangible-Book | 24.45 | |||||
Price-to-Free-Cash-Flow | 29.63 | |||||
Price-to-Operating-Cash-Flow | 26.49 | |||||
EV-to-EBIT | 25.08 | |||||
EV-to-Forward-EBIT | 20.77 | |||||
EV-to-EBITDA | 21.48 | |||||
EV-to-Forward-EBITDA | 19.55 | |||||
EV-to-Revenue | 7.05 | |||||
EV-to-Forward-Revenue | 6.56 | |||||
EV-to-FCF | 30.65 | |||||
Price-to-Projected-FCF | 2.6 | |||||
Price-to-DCF (Earnings Based) | 1.6 | |||||
Price-to-DCF (FCF Based) | 2.57 | |||||
Price-to-Median-PS-Value | 1.07 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.05 | |||||
Price-to-Graham-Number | 5.68 | |||||
Price-to-Net-Current-Asset-Value | 191.35 | |||||
Earnings Yield (Greenblatt) % | 3.99 | |||||
FCF Yield % | 3.41 | |||||
Forward Rate of Return (Yacktman) % | 16.41 |